- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 28.08. | ICU Medical issues infusion pump software correction labeled serious by FDA | ||
| 28.08. | GE HealthCare unveils new cardiology innovations | ||
| 28.08. | J&J's Abiomed removes some Impella heart pump controllers following death | ||
| 28.08. | The top Abbott stories of 2025 so far | ||
| 28.08. | Medtronic Evolut wins FDA nod for expanded redo TAVR indication | ||
| 28.08. | Peytant reports positive tracheobronchial covered stent results | ||
| 28.08. | Zimmer Biomet adds duo of new chief medical advisors | ||
| 27.08. | Bioretec selects its next CEO | ||
| 27.08. | Modular Medical gets insulin pump cartridge production ready for commercial activity | ||
| 27.08. | Airiver Medical wins FDA IDE for pulmonary drug-coated balloon | ||
| 27.08. | Penumbra promotes from within to fill president position | ||
| 27.08. | Philips launches next-gen AI-powered cardiovascular ultrasound offering | ||
| 27.08. | HeartFocus launches first clinical product in the U.S. on Butterfly Network handheld ultrasound | ||
| 27.08. | Ciliatech wins CE mark for implant that treats glaucoma | ||
| 27.08. | Intuitive to lay off 331 workers in California | ||
| 27.08. | Natus Medical denies CeriBell's brain EEG patent infringement claim | ||
| 26.08. | Inspire Medical CFO departs to pursue other opportunities | ||
| 26.08. | GE HealthCare picks former Abbott VP as new chief strategy officer | ||
| 26.08. | Avasa raises $2.8M pre-Series A for micro-artery coupling device | ||
| 26.08. | SetPoint reports first commercial use of neuromod for arthritis | ||
| 26.08. | Envoy Medical clears debt, looks to advance cochlear implant tech | ||
| 26.08. | Henry Schein launches open-architecture digital dental workflow offering | ||
| 26.08. | Pavmed licenses endoscopic esophageal imaging tech out of Duke | ||
| 26.08. | Pulse Biosciences reports first-in-human data for PFA to treat benign thyroid nodules | ||
| 26.08. | Varian completes enrollment in flash radiotherapy study |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .